Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -6.40 | N/A |
| PEG Ratio (TTM) | -0.10 | N/A |
| P/S Ratio (TTM) | 0.20 | N/A |
| P/B Ratio (TTM) | 0.51 | N/A |
| P/FCF Ratio (TTM) | 15.28 | N/A |
| Price to 5YR AVG Earnings Ratio | -0.44 | N/A |
| Price to 5YR AVG FCF Ratio | -2.17 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.57% | N/A |
| ROE (TTM) | -9.13% | N/A |
| Net Profit Margin (TTM) | -3.07% | N/A |
| ROIC 5YR AVG | -10.82% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -138.11% | -373.12% | -198.89% |
| Revenue | 11.35% | 74.07% | 39.60% |
| Net Income | -144.95% | -277.44% | -143.92% |
| Cash Flow | 130.90% | -1,269,131.73% | -761,439.12% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.18 | N/A |
| Quick Ratio (TTM) | 1.18 | N/A |
| D/E Ratio (TTM) | 1.82 | N/A |
| Interest Coverage (TTM) | -0.85 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.30 | N/A |
| LTL to 5YR AVG FCF | -7.39 | N/A |
| Shares Outstanding Growth 5YR AVG | -3.54% | N/A |